Latest News
3D imaging shown to be more effective in diagnosing arthritis
19 June 2018 - Osteoarthritis (OA) is a growing problem around the world. An estimated 10% to 15% of all adults over the age of 60 have some degree of OA, and the condition is becoming more prevalent due to population ageing and an increase in relate...
Amphastar's Isoproterenol Hydrochloride Injection approved by FDA
19 June 2018 - Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has gained US approval for its Isoproterenol Hydrochloride Injection, the company announced on Tuesday.The US Food and Drug Administration (FDA) has approved Amphastar's abbreviated new...
Study Shows Livongo for Diabetes Benefits Patients with Type 2 Diabetes
19 June 2018 - - A new study, published in the Journal of Diabetes Research, has found that use of Livongo for Daiabetes from Mountain View, California-based personalized medicine specialist Livongo, significantly improves the health of people with t...
Seattle Genetics Begins Phase 2 Trial of Tisotumab Vedotin in Cervical Cancer Patients
19 June 2018 - - Bothell, Washington-based cancer treatment developer Seattle Genetics, Inc. (NASDAQ: SGEN) has dosed the first patient in the phase 2 innovaTV 204 clinical trial evaluating the efficacy, safety and tolerability of tisotumab vedotin a...
Results of Phase III Study of R2 vs R-chemo in First-line Follicular Lymphoma Presented at EHA Annual Congress
19 June 2018 - - Dr. Frank Morschhauser of the Centre Hospitalier Universitaire Régional de Lille, Unité GRITA, Lille, France has presented results of RELEVANCE, a Phase III efficacy and safety study of lenalidomide plus rituximab versu...